Welcome to our dedicated page for DXP Enterprises news (Ticker: $DXPE), a resource for investors and traders seeking the latest updates and insights on DXP Enterprises stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DXP Enterprises's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DXP Enterprises's position in the market.
DXP Enterprises, Inc. reported strong first quarter 2024 results with $412.6 million in sales, $0.67 GAAP diluted EPS, and $0.74 non-GAAP diluted EPS. The company saw a 1.4% sequential sales increase, completed multiple acquisitions, and generated $24.1 million in free cash flow. While net income decreased to $11.3 million, DXP remains optimistic about market conditions and growth initiatives for 2024.
DXP Enterprises, Inc. (NASDAQ:DXPE) will release its financial results for the first quarter of 2024 on May 8th after the market closes. A conference call will be held on May 9th at 10:30 A.M. Central Time, with a webcast available on the company's website. Earnings press release, slides, and other presentation materials will be posted on the Investor Relations section of DXP's website.